FDA Brief

Warning letters Food

FDA warning letter to

Gluten Free Remedies LLC

LowIssued Apr 15, 2025Posted May 20, 2025Human Foods Program

FDA warns Gluten Free Remedies that Sulbutiamine Plus Brain Support is misbranded because sulbutiamine is not a dietary ingredient.

What happened

FDA reviewed the label of Sulbutiamine Plus Brain Support and found the label declares sulbutiamine as a dietary ingredient. FDA says sulbutiamine does not fit any category of dietary ingredient defined in section 201(ff)(1) of the Act, so declaring it makes the label false or misleading. The letter is dated April 15, 2025; no inspection is mentioned.

What FDA found

  1. Sulbutiamine is not a vitamin, mineral, herb, botanical, amino acid, dietary substance, or a concentrate/metabolite/extract of one, so it cannot be listed as a dietary ingredient.

    Section 201(ff)(1) of the Act [21 U.S.C. § 321(ff)(1)]
  2. Because the label lists sulbutiamine as a dietary ingredient, the labeling is false or misleading and the product is misbranded.

    Section 403(a)(1) of the Act [21 U.S.C. § 343(a)(1)]
  3. Sending a misbranded product across state lines is a prohibited act.

    Section 301(a) of the Act [21 U.S.C. § 331(a)]

What FDA wants

FDA asks the company to reply in writing within 15 working days describing the specific steps taken to fix the violations and prevent them from happening again, with copies of related documents. If corrective actions cannot be finished in that time, the company must say why and give a completion date.

Who should pay attention

  • supplement brands selling nootropic or brain-health products
  • firms that buy finished supplements from contract manufacturers
  • regulatory and label review teams checking ingredient status

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Psyched Wellness Ltd.

    FDA warned Psyched Wellness that its Calm, Calmer and Santa Amanita muscaria supplements are adulterated new-dietary-ingredient products.

    High risk
  2. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  3. Formulation Technology, Inc.

    FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.

    High risk
  4. Deggeh Foods, Inc.

    FDA says Deggeh Foods sold supplement capsules and Moringa tea as unapproved drugs and violated manufacturing rules.

    High risk